Welcome
Enhance your knowledge of PARP inhibitors in the treatment of advanced ovarian cancer
- Get the latest evidence of PARP inhibitor efficacy from recent clinical trial data
- Learn how PARP inhibitors work by exploring our easy-to-follow diagrams and clear language explanations
- Watch our expert videos to learn from practitioners in the field
Are you aware of the latest treatments for patients with advanced ovarian cancer? PARP inhibitors are an exciting development in the fight against ovarian cancer. Find out how to select the right PARP inhibitor for your patients, and how to manage treatment in order to achieve the best possible outcomes.
Professor Isabelle Ray-Coquard introduces why it is important for healthcare professionals to understand the differences in PARP inhibitors in the treatment and management of ovarian cancer.
Ovarian cancer
Epidemiology, treatment, first-line maintenance strategies
PARPi selection in ovarian cancer
Indications, modes of action, efficacy and safety
Managing ovarian cancer patients on PARPi
Side effects, treatment monitoring and modification
Patient focus case studies
Broaden your knowledge of poly (ADP-ribose) polymerase (PARP) inhibitors and their place in the treatment of advanced ovarian cancer
Congress highlights
Learn the latest from your colleagues: highlights from ASCO 2022
PARP inhibitors for Ovarian Cancer Webinar
Insights into the latest evidence for the use of PARP inhibitors
Meet the experts
As you navigate this Learning Zone, you will hear from our experts, Dr Mansoor Raza Mirza and Professor Isabelle Ray-Coquard to help guide you on your learning journey.
of interest
are looking at
saved
next event
This content has been developed independently by Medthority who previously received educational funding in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.